GREDEFIN
Dead / Abandoned — Abandoned — no statement of use filed (as of 27 Apr 2009)
What this means for you
This application is over — abandoned 27 Apr 2009. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78695062
- Mark type
- Stylized text
- Filed
- 18 Aug 2005
- Published for opposition
- 02 Jan 2007
- Abandoned
- 27 Apr 2009
- Attorney of record
- Nadine P. Flynn
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibody; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents
Owner
- Bristol-Myers Squibb Company, New York, NY, US
- Bristol-Myers Squibb Company, New York, NY, US
Prosecution history
- 27 Apr 2009 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 27 Apr 2009 — ABANDONMENT - NO USE STATEMENT FILED
- 13 Aug 2008 — SOU EXTENSION 3 GRANTED
- 13 Aug 2008 — SOU EXTENSION 3 FILED
- 13 Aug 2008 — SOU TEAS EXTENSION RECEIVED
- 10 Feb 2008 — SOU EXTENSION 2 GRANTED
- 10 Feb 2008 — SOU EXTENSION 2 FILED
- 10 Feb 2008 — SOU TEAS EXTENSION RECEIVED
- 14 Sept 2007 — SOU EXTENSION 1 GRANTED
- 14 Sept 2007 — SOU EXTENSION 1 FILED
- 14 Sept 2007 — SOU TEAS EXTENSION RECEIVED
- 27 Mar 2007 — NOA MAILED - SOU REQUIRED FROM APPLICANT
- 02 Jan 2007 — PUBLISHED FOR OPPOSITION
- 13 Dec 2006 — NOTICE OF PUBLICATION
- 13 Nov 2006 — LAW OFFICE PUBLICATION REVIEW COMPLETED